Human AD/CBD tau seeds induce disease-specific mouse tau pathology
Supporting evidence
- Seeded aggregates are phosphorylated mouse tau with strain biochemistry
- CBD tau seeds aggregate faster than AD in wildtype mice
Proving that human tau strains faithfully template their precise atomic folds in wildtype mouse brains, this work confirms a foundational but untested pillar of the prion hypothesis and opens a tractable model for strain-specific neurodegeneration.
Intracerebral injection of tau filaments from Alzheimer's disease or corticobasal degeneration human brains into wildtype mice induces the assembly of mouse tau into filaments that retain the atomic structure of the human disease-specific seeds, establishing that tau strains propagate through templated conformational seeding and produce disease-specific pathological patterns with distinct cellular targeting, morphology, and aggregation kinetics.
Most neurodegenerative diseases are believed to spread through the brain by prion-like mechanisms, where filamentous protein assemblies self-propagate by templated seeding. Distinct conformations of amyloid filaments are thought to provide the physical basis for the strains that lead to different diseases. However, a central pillar of the prion hypothesis, that strains retain their structural identity upon transmission, has not been demonstrated. Here we show that the injection of tau filaments from the brains of individuals with Alzheimer’s disease or corticobasal degeneration into the brains of wildtype mice leads to the seeded assembly of amyloid filaments made of mouse tau with the same structures as those of the seeds. Thereby, we establish that, like prion strains, tau filaments propagate through templated seeding, and that the mouse is a suitable model to study the molecular mechanisms by which distinct tau folds drive disease-specific pathology in the brain.